Kreimer Lab

The main focus of our group is to develop predictive models of transcriptional regulation by integrating large-scale datasets to shed light on regulatory processes that are condition-specific. In conjunction with experimental validation, we will leverage such techniques to identify functional variants and mechanisms of action driving disease.

CABM 236
Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation
March 21, 2022
Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation
Nature Communications

Read More › about Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation

Conversations with CABM Director: An interview with Dr. Anat Kreimer
March 31, 2021
Conversations with CABM Director: An interview with Dr. Anat Kreimer
YouTube

Read More › about Conversations with CABM Director: An interview with Dr. Anat Kreimer